Topp-2.JPG   

HOME    AFL™ MONITORING POSTPARTUM CARE ABOUT OBSTECARE NEWS RESOURCES CONTACT

News & Events

December 30, 2014

Obstecare issues new shares

November 15, 2014

Final data from a large study supports the benefit of AFL monitoring

November 1, 2014

Obstecare introduces Ebb and Jetty postpartum care products in Norway at national congress

June 06, 2014

Obstecare participating at the  European Congress on Perinatal Medicine, in Florens, Italy

May 30, 2014

Patent approved in Japan

May 13, 2014

Data from National Maternity Hospital confirms benefit of AFL monitoring

January 28, 2014

Preliminary data from large study supports the benefit of AFL monitoring

January 15, 2014

Poster on AFL -monitoring will be presented at the 34th SMFM Annual Meeting in New Orleans

December 30, 2014                                                                                                           ↑ TOP

Obstecare issues new shares

Obstecare AB has issued new shares to a total amount of 2,4 MSEK to secure furher developement and welcomes Almi Invest AB and Mr. Bo Lundblad as new owners.

November 15, 2014                                                                                                           ↑ TOP

Final data from a large study supports the benefit of AFL monitoring

During 2013 a large international multicenter study including 3000 delivering women was closed. Final data from the study was presented in June at the European Congress for Perinatal Medicine in Italy and in August at the Swedish Congress for Obstetricians and Gynecologists.

Data support earlier published result, that lactate levels in amniotic fluid (AFL) has a high correlation with labour outcome. AFL can be used as a good bedside tool when treating women suffering from a dysfunctional labour.

By using AFL monitoring in combination with Oxytocin infusion, the frequency of operative deliveries can be reduced and delivery times optimized.

The study was performed 2011-2013 and included approximately 3000 delivering women. The study was run in an international collaboration between hospitals in Sweden, France, Switzerland and Tanzania. In the study healthy primipara women with a spontaneous onset of labour were included.

November 1, 2014                                                                                                           ↑ TOP

Obstecare introduces Ebb and Jetty postpartum care products in Norway at national congress

Obstecare will participate at the congress Norsk Perinatal Dager, Hurtigruta, Trollfjord November 11-13 2014. Besides the presentation of its AFL -monitoring system the Ebb and Jetty postpartum care products will be introduced on the Norwegian market.

June 06, 2014                                                                                                                  ↑ TOP

Obstecare participating at the  European Congress on Perinatal Medicine, in Florens, Italy

At the European Congress on Perinatal Medicine, in Florens, June 8-10, 2014 Obstecare will present the AFL-monitoring solution for an efficient delivery care.

Dr. Eva Itzel will present the large Dysfunctional Labour study including more than 3000

delivering women. The study was run in an international collaboration between hospitals in Sweden, France, Switzerland and Tanzania.

May 30, 2014

Patent approved in Japan                                                                   ↑ TOP   

With 8 approved claims Obstecare is consolidating the trademark AFL

May 13, 2014                                                                                                                   ↑ TOP  

Data from National Maternity Hospital confirms benefit of AFL monitoring

At SMFM Annual Meeting in New Orleans, USA, February 3 - February 8, 2014 the National Maternity Hospital in Dublin, Ireland presented data from their AFL monitoring study.

The Irish study included 905 delivering women. The data presented confirmed previously published result that a high level of lactate in amniotic fluid (AFL) has a high correlation with Cesarean section. The Irish study also confirmed that “increasing AFL was associated with higher total oxytocin dosage”. In the study, Spontaneously labouring Single Cephalic Nulliparous women with a gestational age > 37 weeks of gestation were included.

These findings confirm that AFL can be used as a good bedside tool when treating women suffering from a dysfunctional labour. By using AFL monitoring in combination with oxytocin infusion, the frequency of operative deliveries can be reduced and delivery times optimized.

January 28, 2014                                                                                                             ↑ TOP

Preliminary data from large study supports the benefit of AFL monitoring

During 2013 a large international multicenter study including 3000 delivering women was closed. Preliminary data from the study support earlier published result, that lactate levels in amniotic fluid (AFL) has a high correlation with labour outcome. AFL can be used as a good bedside tool when treating women suffering from a dysfunctional labour.

By using AFL monitoring in combination with oxytocin infusion, the frequency of operative deliveries can be reduced and delivery times optimized.

More data from the study will continuously be presented during 2014 starting with SMFM Annual Meeting in New Orleans February 3- February 8, 2014.

The study was performed 2011-2013 and included approximately 3000 delivering women. The study was run in an international collaboration between hospitals in Sweden, France, Switzerland and Tanzania. In the study healthy primipara women with a spontaneous onset of labour were included.

January 15, 2014                                                                                                              ↑ TOP

Poster on AFL -monitoring will be presented at the 34th SMFM Annual Meeting in New Orleans

During the 34th SMFM Annual Meeting - The Pregnancy Meeting in New Orleans, IL February 8-10, Dr. Eva Itzel will present a poster on the benefit of AFL -monitoring for predicting the outcome of labour.

END

             

Obstecare AB

Karolinska Institutet Science Park

Fogdevreten 2

SE 171 65 SOLNA

Sweden

© 2017 Obstecare AB

Telephone:  +46 8 751 56 27

E-mail:         info@obstecare.com

facebooklogo-3.png twitter-icon.png linked-in.png

AFL monitoring system is currently not commercially available in the United States

                              ©